Found: 8
Select item for more details and to access through your institution.
Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims Data.
- Published in:
- Neuroepidemiology, 2023, v. 57, n. 2, p. 121, doi. 10.1159/000529583
- By:
- Publication type:
- Article
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data.
- Published in:
- Thrombosis Journal, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12959-022-00389-9
- By:
- Publication type:
- Article
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data.
- Published in:
- Thrombosis Journal, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12959-022-00389-9
- By:
- Publication type:
- Article
Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data Analysis.
- Published in:
- Digestion, 2021, v. 102, n. 2, p. 216, doi. 10.1159/000503859
- By:
- Publication type:
- Article
Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 1, p. 247, doi. 10.1007/s40120-021-00311-x
- By:
- Publication type:
- Article
A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022).
- Published in:
- EJHaem, 2024, v. 5, n. 2, p. 346, doi. 10.1002/jha2.888
- By:
- Publication type:
- Article
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds.
- Published in:
- ClinicoEconomics & Outcomes Research, 2022, v. 14, p. 319, doi. 10.2147/CEOR.S357540
- By:
- Publication type:
- Article
Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn's Disease patients: A retrospective analysis using German claims data.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221130554
- By:
- Publication type:
- Article